Beta Bionics, Inc.·4

May 26, 6:00 PM ET

MICHEL GERARD J 4

4 · Beta Bionics, Inc. · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Beta Bionics (BBNX) Director Michel Gerard Receives 16,965-Share Award

What Happened

  • Director Michel Gerard received a grant of 16,965 restricted stock units (RSUs) on May 21, 2026. The reported acquisition price is $0.00, so the immediate cash value recorded in the Form 4 is $0. These RSUs were granted under the issuer's 2025 Equity Incentive Plan (see footnote).

Key Details

  • Transaction date: 2026-05-21; Report filed: 2026-05-26 (Form 4 accession 0001235644-26-000008).
  • Transaction type/code: A — Award/Grant (restricted stock unit award).
  • Shares granted: 16,965 RSUs; price per share reported: $0.00; total reported cash value: $0.
  • Footnote: F1 — Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
  • Shares owned after transaction: Not specified in the provided filing details.
  • No indication in the provided data that this was part of a 10b5-1 plan, tax withholding, or a sale; filing timeliness (late/on-time) not indicated here.

Context

  • RSU awards are a form of compensation that typically vest over time or upon meeting performance conditions; they do not require the insider to pay cash at grant. They are not an immediate market purchase and therefore are not a direct bullish or bearish trading signal by themselves. For retail investors, such grants are common for executive/director compensation and should be evaluated along with vesting terms, company performance, and total insider holdings if available.

Insider Transaction Report

Form 4
Period: 2026-05-21
Transactions
  • Award

    Common Stock

    [F1]
    2026-05-21+16,96533,509 total
Footnotes (1)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
Signature
/s/ Stephen Feider, Attorney-in-Fact|2026-05-26

Documents

1 file
  • 4
    form4-05262026_060533.xmlPrimary